Cybersecurity for Entrepreneurs: Featuring Laura Viaches
Speaker A describes a pharmaceutical market‑access consulting practice that serves clients across the entire product lifecycle—from early‑stage ideas seeking venture funding, through Phase 3 development, launch preparation, and post‑market products. The core premise is that market‑access strategy is never too early to begin and never too late to improve. The consultant offers strategy development, pressure‑testing of existing plans, and acts as a technical thought partner in the complex market‑access environment. Additionally, the service extends to companies offering complementary products or services, helping them navigate market‑access challenges, and to venture‑capital and private‑equity firms, assisting with company valuation and guiding portfolio companies toward profitability.
